MDX/Votrient and MDX/Sutent trial expansion

alice124
Member Posts: 896 Member
Met with John's Dr. today. We had several questions and he sat with us for some time. While talking about the MDX/Votrient and MDX/Sutent trial, we talked about the promise of early results.
He stated that the trial is being expanded; will probably be in August. This expansion will only take kidney cancer patients who have not yet received treatment. He mentioned specifically papillary and chromophobe in addition to clear cell. He said the success of this trial has made them to want to expand the research to see how many cancer types might benefit from trial.
He stated that the trial is being expanded; will probably be in August. This expansion will only take kidney cancer patients who have not yet received treatment. He mentioned specifically papillary and chromophobe in addition to clear cell. He said the success of this trial has made them to want to expand the research to see how many cancer types might benefit from trial.
0
Discussion Boards
- 119.2K All Discussion Boards
- 5 CSN Information
- 5 Welcome to CSN
- 119.3K Cancer specific
- 2.7K Anal Cancer
- 424 Bladder Cancer
- 297 Bone Cancers
- 1.6K Brain Cancer
- 28.1K Breast Cancer
- 377 Childhood Cancers
- 27.7K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.1K Gynecological Cancers (other than ovarian and uterine)
- 12.6K Head and Neck Cancer
- 6.2K Kidney Cancer
- 643 Leukemia
- 767 Liver Cancer
- 4K Lung Cancer
- 5K Lymphoma (Hodgkin and Non-Hodgkin)
- 217 Multiple Myeloma
- 7.1K Ovarian Cancer
- 35 Pancreatic Cancer
- 477 Peritoneal Cancer
- 5K Prostate Cancer
- 1.1K Rare and Other Cancers
- 521 Sarcoma
- 693 Skin Cancer
- 633 Stomach Cancer
- 190 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.7K Uterine Cancer
- 6.2K Other Discussion Boards